Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chagpar, A.
Right arrow Articles by Kuerer, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chagpar, A.
Right arrow Articles by Kuerer, H. M.
Related Collections
Right arrow Surgery
Annals of Surgical Oncology 10:628-634 (2003)
© 2003 Society of Surgical Oncology

ORIGINAL ARTICLES

Chest Wall Recurrence After Mastectomy Does Not Always Portend a Dismal Outcome

Anees Chagpar, MD, MSc, Funda Meric-Bernstam, MD, Kelly K. Hunt, MD, Merrick I. Ross, MD, Massimo Cristofanilli, MD, S. Eva Singletary, MD, Thomas A. Buchholz, MD, Frederick C. Ames, MD, Sylvie Marcy, BSN, Gildy V. Babiera, MD, Barry W. Feig, MD, Gabriel N. Hortobagyi, MD and Henry M. Kuerer, MD, PhD

From the Departments of Surgical Oncology (AC, FM-B, KKH, MIR, SES, FCA, SM, GVB, BWF, HMK), Medical Oncology (MC, GNH), and Radiation Oncology (TAB), The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Correspondence: Address correspondence and reprint requests to: H. M. Kuerer, MD, PhD, Department of Surgical Oncology, Box 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030; Fax: 713-792-4689; E-mail: hkuerer{at}mdanderson.org

Background: Chest wall recurrence (CWR) after mastectomy often forecasts a grim prognosis. Predictors of outcome after CWR, however, are not clear.

Methods: From 1988 to 1998, 130 patients with isolated CWRs were seen at our center. Clinicopathologic factors were studied by univariate and multivariate analyses for distant metastasis–free survival after CWR. The median post-CWR follow-up was 37 months.

Results: Initial nodal status was the strongest predictor of outcome by univariate analysis. Other significant factors included initial T4 disease, primary lymphovascular invasion, treatment of the primary tumor with neoadjuvant therapy or radiation, time to CWR >24 months, and treatment for CWR (surgery, radiation, or multimodality therapy). Multivariate analysis also found initial nodal status to have the greatest effect; time to CWR and use of radiation for CWR were also independent predictors. Three groups of patients were identified. Low risk was defined by initial node-negative disease, time to CWR >24 months, and radiation for CWR; intermediate risk had one or two favorable features; and high risk had none. The median distant metastasis–free survival after CWR was significantly different among these groups (P < .0001).

Conclusions: Patients with CWR are a heterogeneous population. Patients with initial node-negative disease who develop CWR after 24 months have an optimistic prognosis, especially if they are treated with radiation.

Key Words: Breast cancer • Chest wall recurrence • Prognosis • Mastectomy




This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
A. A. Santillan, J. V. Kiluk, J. M. Cox, T. L. Meade, N. Allred, D. Ramos, J. King, and C. E. Cox
Outcomes of Locoregional Recurrence after Surgical Chest Wall Resection and Reconstruction for Breast Cancer
Ann. Surg. Oncol., May 1, 2008; 15(5): 1322 - 1329.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.